Dresdner offers Ucits III-compliant volatility tracker funds

The new funds, called Dresdner equity volatility arbitrage (Deva) 80 fund and DEVA 90 alpha fund, will offer returns on equity volatility through an undertaking for collective investments in transferable securities (Ucits III) compliant structure. They will be sterling-denominated, open-ended investment companies (OEICs) based in the UK and authorised by financial watchdog the Financial Services Authority. The OEICS will be listed on the London Stock Exchange, offering investors daily liquidity.

The Deva 80 and Deva 90 alpha funds aim to achieve absolute returns of 4% and 9% per year, respectively, above the Bank of England base rate. They expect to do this with relatively low levels of volatility – 2-3% for the Deva 80 fund and 4-5% for the Deva 90 alpha fund. Both funds intend to have an upwardly adjusted capital protection of 90% and 80%, accordingly, on the highest net asset value achieved on launch and at monthly rebalancing dates.

“These funds offer investors the opportunity to benefit from the transparent charges, daily dealing and ease of administration that they would expect from a UK-based OEIC product, while enjoying exposure to an asset class that has previously been unavailable to many investors,” said Andy Halford, London-based head of structured products at Kleinworth Benson.

The Gresham defined funds platform was introduced by Dresdner Kleinwort in the third quarter of 2005, providing a number of structured products for institutional and asset management clients based on a wide variety of asset classes.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here